Skip Navigation

Profile

K. C. Balaji, M.D.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

169 Ratings
10 Comments
 

K. C. Balaji, M.D.

Professor,


Clinical Interests

Minimally Invasive Surgery, Urologic Oncology, Robotic Urologic Surgery, Laparoscopic Surgery

Contact Information

Returning Patient Appointments: 336-716-4131
Department: 336-716-4131

Insurance Accepted »

Education & Training

  • M.B.,B.S., Madras Univ Faculty Of Medicine Madras-India, 1986
  • Residency, Surgery, Bronx-Lebanon Hosp Ctr, 1993
  • Residency, Urology, Univ Massachusetts Med Ctr, 1997
  • Fellowship, Urologic Oncology, Memorial Sloan Kettering Cance, 1999

Board Certifications

  • American Board of Urology, Urology

Memberships

  • Soc Of Basic Urologic Research
  • Soc Of Urologic Oncology
  • American Urological Assn

NPI Number

  • 1558314484
K. C. Balaji, M.D.

Doctor Rating

4.5 out of 5

169 Ratings
10 Comments
 

K. C. Balaji, M.D.

Professor, Urology
Cancer Biology
Institute for Regenerative Medicine

Research Interests

Prostatic Neoplasms; Zinc; Mitochondrial Proteins; Fluorodeoxyuridylate; Cell Communication
More »

Contact Information

Academic: 336-716-5690 | Department: 336-716-4131

Recent Publications

Cell line modeling to study biomarker panel in prostate cancer. NickKholgh B, Fang X, Winters SM, Raina A, Pandya KS, Gyabaah K, Fino N, Balaji KC.. Prostate. 2016;76(3):245-258.

E-cadherin facilitates protein kinase D1 activation and subcellular localization. Li Z, Zhang C, Chen L, Li G, Qu L, Balaji KC, Du C.. J Cell Physiol. 2016;231(12):2741-2748.

Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Stuart CH, Singh R, Smith TL, D'Agostino R Jr, Caudell D, Balaji KC, Gmeiner WH.. Nanomedicine (Lond). 2016;11(10):1207-1222.

Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate cancer in bone. Sharma S, Xing F, Liu Y, Wu K, Said N, Pochampally R, Shiozawa Y, Lin HK, Balaji KC, Watabe K.. J Biol Chem. 2016;291(37):19351-63.

Rapid bench to bed in management of metastatic prostate cancer [editorial]. Balaji KC.. Indian J Urol. 2016;32(4):255-256.

The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn(2+) -chelation and inhibiting the serine protease Omi/HtrA2. Gmeiner WH, Boyacioglu O, Stuart CH, Jennings-Gee J, Balaji KC.. Prostate. 2015;75(4):360-369.

Novel in vivo model for combinatorial fluorescence labeling in mouse prostate. Fang X, Gyabaah K, Nickkholgh B, Cline JM, Balaji KC.. Prostate. 2015;75(9):988-1000.

Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience [editorial comment]. Balaji KC.. J Urol. 2015;193(6):1916-1917.

Differential expression of novel PKD1 related biomarker panel in African American men with prostate cancer [abstract]. Nickkholgh B, Fang XL, Winters SM, Fino N, Balaji KC.. Cancer Res. 2015;75(15 Suppl):4342.

Autophagy: friend or foe for progression and treatment of urothelial carcinoma [editorial]. Balaji KC.. J Urol. 2014;191(6):1644-1645.

Prorainbow: a novel in vivo prostate mouse model to track the origin of prostate cancer [abstract]. Wicks EE, Fang XL, Balaji KC.. Tissue Eng Part A. 2014;20(Suppl 1):S139-S140.

Biological basis of aggressive phenotype in African-American prostate cancer cell line [abstract]. Nickkholgh B, Fang XL, Gyabaah K, Balaji KC.. Cancer Res. 2014;74(19 Suppl):A4000.

Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK.. J Endourol. 2013;27(8):1046-1050.

Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC.. PLoS One. 2013;8(9):e75187.

Novel 3D co-cultural model for epithelial-stromal cells interaction in prostate cancer [abstract]. Fang XL, Sivanandane S, Gyabaah K Balaji KC.. Cancer Res. 2013;73(8 Suppl 1):A4078.

Metastatic potential of a renal mass according to original tumour size at presentation [editorial comment]. Balaji KC.. BJU Int. 2012;109(2):194.

Beta-catenin phosphorylated at threonine 120 antagonizes generation of active beta-catenin by spatial localization in trans-Golgi network. Du C, Zhang C, Li Z, Biswas MHU, Balaji KC.. PLoS ONE. 2012;7(4):e33830.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Urology

Clinical Interests

Minimally Invasive Surgery, Urologic Oncology, Robotic Urologic Surgery, Laparoscopic Surgery
K. C. Balaji, M.D.

K. C. Balaji, M.D.

Professor, Urology
Cancer Biology
Institute for Regenerative Medicine

Doctor Rating

4.5 out of 5

K. C. Balaji, M.D.169 Ratings
10 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.5
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.5
CP spoke using clear language
4.6
Friendliness/courtesy of CP
4.6
Likelihood of recommending CP
4.5
Patients' confidence in CP
4.6
Time CP spent with patient
4.4
Wait time at clinic
3.9



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/2/2017

Dr. Balaji spent a good deal of time talking to me about my condition and explaining all my options for treatment and answering any and all questions I had.

4/7/2017

Dr. Balaji is very empathetic and comforting. He explanation of a difficult situation gives me a sense of peace and encouragement. I feel lucky to have Dr. Balaji as one of my providers. I would definitely recommend Dr. Balaji to other patients, family and friends.

2/16/2017

*Dr. Balaji is the best doctor I have ever had. He is professional and cares for his patients. I have complete confidence in his medical skills and advice. I hold deep respect for *Dr. Balaji. He is a man of great integrity!

2/15/2017

great doctor

2/7/2017

Very good. #1. *Kethandapatti Balaji

2/2/2017

outstanding service and doctor

9/2/2016

A professional in discussing my situation.

8/23/2016

A wonderful doctor.

8/3/2016

The doctor explain my condition to me and told me what he think we should do. He ask who I felt about it or did I have any question about what he had said. I like it when the doctor let the patient has a voice in their care

7/29/2016

Everything OK.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Five Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is RenewedMagnet Hospital Recognition2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.